Open Market Insiders Trades - Sells only
This list includes insiders general transaction with codes filed in Form 4 from SEC:
- S - Open market or private sale of non-derivative or derivative security
- V - Transaction voluntarily reported earlier than required
| Ticker | Insider | Transaction Type | Ownership Type | Shares Traded | Value / Price | Filing Date |
|---|---|---|---|---|---|---|
|
PANW
|
Nikesh Arora
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 296,838 Reduced 48.31% |
$49,316,665
$166.14 p/Share
|
Apr 03
2025 |
|
MRAM
|
Sanjeev Aggarwal
PRESIDENT AND CEO |
SELL
Open market or private sale
|
Direct | 12,950 Reduced 2.03% |
$61,771
$4.77 p/Share
|
Apr 03
2025 |
|
ETSY
|
Toni Thompson Nadal
CHIEF HUMAN RESOURCES OFFICER |
SELL
Open market or private sale
|
Direct | 1,444 Reduced 70.92% |
$70,423
$48.77 p/Share
|
Apr 03
2025 |
|
ETSY
|
Merilee Buckley
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 1,676 Reduced 100.0% |
$81,989
$48.92 p/Share
|
Apr 03
2025 |
|
MAA
|
Timothy Argo
EVP, Chief Strategy & Analysis |
SELL
Open market or private sale
|
Direct | 94 Reduced 0.53% |
$15,626
$166.24 p/Share
|
Apr 03
2025 |
|
MAA
|
Melanie Carpenter
EVP & CHRO |
SELL
Open market or private sale
|
Direct | 472 Reduced 2.18% |
$78,465
$166.24 p/Share
|
Apr 03
2025 |
|
MAA
|
H Eric Bolton Jr
President and CEO |
SELL
Open market or private sale
|
Direct | 4,358 Reduced 1.33% |
$724,473
$166.24 p/Share
|
Apr 03
2025 |
|
OLLI
|
Valk Eric Van Der
President and CEO |
SELL
Open market or private sale
|
Direct | 525 Reduced 7.17% |
$59,293
$112.94 p/Share
|
Apr 03
2025 |
|
OLLI
|
James J Comitale
SVP, General Counsel |
SELL
Open market or private sale
|
Direct | 5,485 Reduced 54.27% |
$622,712
$113.53 p/Share
|
Apr 03
2025 |
|
MAA
|
Robert J. Del Priore
EVP, General Counsel |
SELL
Open market or private sale
|
Direct | 1,150 Reduced 2.02% |
$191,176
$166.24 p/Share
|
Apr 03
2025 |
|
JOBY
|
Didier Papadopoulos
President of Aircraft OEM |
SELL
Open market or private sale
|
Direct | 7,655 Reduced 9.12% |
$43,327
$5.66 p/Share
|
Apr 03
2025 |
|
CNO
|
Gary C Bhojwani
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 15,000 Reduced 6.89% |
$602,550
$40.17 p/Share
|
Apr 03
2025 |
|
MAA
|
Aubrey Clay Holder
EVP, CFO |
SELL
Open market or private sale
|
Direct | 28 Reduced 0.33% |
$4,654
$166.24 p/Share
|
Apr 03
2025 |
|
ROK
|
Matheus De A G Viera Bulho
SVP Software and Control |
SELL
Open market or private sale
|
Direct | 293 Reduced 13.23% |
$75,500
$257.68 p/Share
|
Apr 02
2025 |
|
AIP
|
K Charles Janac
President and CEO |
SELL
Open market or private sale
|
Direct | 7,150 Reduced 2.2% |
$50,908
$7.12 p/Share
|
Apr 02
2025 |
|
PEN
|
Thomas Wilder
Director |
SELL
Open market or private sale
|
Indirect | 360 Reduced 0.0% |
$96,094
$266.93 p/Share
|
Apr 02
2025 |
|
PEN
|
Adam Elsesser
CEO and President |
SELL
Open market or private sale
|
Direct | 16,565 Reduced 23.99% |
$4,510,980
$272.32 p/Share
|
Apr 02
2025 |
|
DGX
|
J. E. Davis
CEO and President |
SELL
Open market or private sale
|
Direct | 39,191 Reduced 23.49% |
$6,613,089
$168.74 p/Share
|
Apr 02
2025 |
|
AIP
|
Paul L Alpern
VP and General Counsel |
SELL
Open market or private sale
|
Direct | 2,878 Reduced 3.19% |
$20,491
$7.12 p/Share
|
Apr 02
2025 |
|
AIP
|
Laurent R Moll
Chief Operating Officer |
SELL
Open market or private sale
|
Direct | 4,703 Reduced 0.96% |
$33,485
$7.12 p/Share
|
Apr 02
2025 |
|
AIP
|
Nicholas B. Hawkins
VP and Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 3,888 Reduced 2.1% |
$27,682
$7.12 p/Share
|
Apr 02
2025 |
|
DGX
|
Karthik Kuppusamy
SVP, Clinical Solutions |
SELL
Open market or private sale
|
Direct | 2,555 Reduced 19.46% |
$434,350
$170.0 p/Share
|
Apr 02
2025 |
|
APGE
|
Carl Dambkowski
Chief Medical Officer |
SELL
Open market or private sale
|
Direct | 3,860 Reduced 1.54% |
$141,777
$36.73 p/Share
|
Apr 02
2025 |
|
APPN
|
Abdiel Capital Advisors, LP |
SELL
Open market or private sale
|
Indirect | 57,975 Reduced 0.0% |
$1,698,667
$29.3 p/Share
|
Apr 02
2025 |
|
MNPR
|
Tactic Pharma LLC
> 10% Shareholder |
SELL
Open market or private sale
|
Direct | 33,334 Reduced 3.9% |
$1,166,690
$35.0 p/Share
|
Apr 02
2025 |
|
ALAB
|
Manuel Alba
Director |
SELL
Open market or private sale
|
Indirect | 63,000 Reduced 0.0% |
$3,958,290
$62.83 p/Share
|
Apr 02
2025 |
|
SMR
|
Jose N Reyes Jr
Chief Technology Officer |
SELL
Open market or private sale
|
Indirect | 33,000 Reduced 0.0% |
$499,290
$15.13 p/Share
|
Apr 02
2025 |
|
MDB
|
Srdjan Tanjga
Interim CFO |
SELL
Open market or private sale
|
Direct | 525 Reduced 7.57% |
$91,339
$173.98 p/Share
|
Apr 02
2025 |
|
MDB
|
Cedric Pech
President, Field Operations |
SELL
Open market or private sale
|
Direct | 1,690 Reduced 2.85% |
$292,809
$173.26 p/Share
|
Apr 02
2025 |
|
MDB
|
Thomas Bull
Chief Accounting Officer |
SELL
Open market or private sale
|
Direct | 301 Reduced 2.02% |
$52,148
$173.25 p/Share
|
Apr 02
2025 |
|
MDB
|
Dev Ittycheria
President & CEO |
SELL
Open market or private sale
|
Direct | 18,512 Reduced 6.44% |
$3,207,389
$173.26 p/Share
|
Apr 02
2025 |
|
WDAY
|
Carl M. Eschenbach
CEO |
SELL
Open market or private sale
|
Indirect | 3,125 Reduced 0.0% |
$731,437
$234.06 p/Share
|
Apr 02
2025 |
|
GO
|
Andrea Renee Bortner
Officer |
SELL
Open market or private sale
|
Direct | 1,931 Reduced 6.65% |
$26,628
$13.79 p/Share
|
Apr 02
2025 |
|
POWI
|
Doug Bailey
VP Marketing |
SELL
Open market or private sale
|
Direct | 1,088 Reduced 1.27% |
$55,368
$50.89 p/Share
|
Apr 02
2025 |
|
POWI
|
Balu Balakrishnan
President and CEO |
SELL
Open market or private sale
|
Indirect | 9,544 Reduced 0.0% |
$488,557
$51.19 p/Share
|
Apr 02
2025 |
|
POWI
|
Radu Barsan
VP of Technology, Engineering |
SELL
Open market or private sale
|
Direct | 1,672 Reduced 3.69% |
$85,088
$50.89 p/Share
|
Apr 02
2025 |
|
POWI
|
Gagan Jain
VP, Worldwide Sales |
SELL
Open market or private sale
|
Direct | 402 Reduced 1.91% |
$20,457
$50.89 p/Share
|
Apr 02
2025 |
|
POWI
|
Sandeep Nayyar
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 1,929 Reduced 1.77% |
$98,166
$50.89 p/Share
|
Apr 02
2025 |
|
POWI
|
Clifford Walker
VP Corporate Development |
SELL
Open market or private sale
|
Direct | 1,088 Reduced 0.76% |
$55,368
$50.89 p/Share
|
Apr 02
2025 |
|
BCYC
|
Travis Alvin Thompson
CHIEF ACCOUNTING OFFICER |
SELL
Open market or private sale
|
Direct | 210 Reduced 0.65% |
$1,684
$8.02 p/Share
|
Apr 02
2025 |
|
BCYC
|
Michael Charles Ferguson Hannay
CHIEF PROD & SUPPLY CHAIN OFF |
SELL
Open market or private sale
|
Direct | 467 Reduced 0.84% |
$3,745
$8.02 p/Share
|
Apr 02
2025 |
|
BCYC
|
Alistair Milnes
CHIEF OPERATING OFFICER |
SELL
Open market or private sale
|
Direct | 1,133 Reduced 1.14% |
$9,086
$8.02 p/Share
|
Apr 02
2025 |
|
BCYC
|
Kevin Lee
CHIEF EXECUTIVE OFFICER |
SELL
Open market or private sale
|
Direct | 2,237 Reduced 0.45% |
$17,940
$8.02 p/Share
|
Apr 02
2025 |
|
BCYC
|
Michael Skynner
CHIEF TECHNOLOGY OFFICER |
SELL
Open market or private sale
|
Direct | 814 Reduced 0.66% |
$6,528
$8.02 p/Share
|
Apr 02
2025 |
|
BCYC
|
Alethia Young
Chief Financial Officer |
SELL
Open market or private sale
|
Direct | 215 Reduced 0.47% |
$1,724
$8.02 p/Share
|
Apr 02
2025 |
|
SEMR
|
Dmitry Melnikov
Director |
SELL
Open market or private sale
|
Direct | 1,405 Reduced 0.05% |
$13,277
$9.45 p/Share
|
Apr 02
2025 |
|
GME
|
Daniel William Moore
PFO and PAO |
SELL
Open market or private sale
|
Direct | 1,608 Reduced 5.12% |
$36,228
$22.53 p/Share
|
Apr 02
2025 |
|
XMTR
|
Randolph Altschuler
Chief Executive Officer |
SELL
Open market or private sale
|
Direct | 9,331 Reduced 2.76% |
$234,767
$25.16 p/Share
|
Apr 02
2025 |
|
GME
|
Mark Haymond Robinson
General Counsel and Secretary |
SELL
Open market or private sale
|
Direct | 4,687 Reduced 11.07% |
$105,598
$22.53 p/Share
|
Apr 02
2025 |
|
PTCT
|
Lee Scott Golden
EVP & CHIEF MEDICAL OFFICER |
SELL
Open market or private sale
|
Direct | 897 Reduced 1.17% |
$42,114
$46.95 p/Share
|
Apr 02
2025 |